Pediatric allergy study. (Product Marketplace).
The Preventive Allergy Treatment (PAT) study, conducted at six pediatric centers in Europe, followed the progress of disease in 205 children ages 6 to 14 with proven allergies to birch, grass pollen, or both. The children were randomly assigned to receive either medications alone to control the allergy symptoms or those medications and shots that treated their allergic condition. After 3 years of treatment, 24% of the children who received allergy shots developed mild asthma symptoms, compared with 44% of those who did not receive the treatment. Those receiving allergy shots also experienced less airway inflammation and fewer allergy symptoms.
Circle 161 on Reader Service Card
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Advertising; The Preventive Allergy Treatment study|
|Publication:||Ear, Nose and Throat Journal|
|Article Type:||Brief Article|
|Date:||Apr 1, 2002|
|Previous Article:||Throat lubricant/moisturizer. (Product Marketplace).|
|Next Article:||Euromed Clinic success. (Editorial).|